April 11, 2006
The medical optic corporate giant Bausch & Lomb was
forced to suspend all U.S. shipping of the ReNu MoistureLoc
brand contact lens solution on April 11, 2006 after the FDA
was alerted to a serious eye infection linked to the product.
The FDA was warned by the Center for Disease Control and
Prevention of 109 initial reports of a potentially devastating
fungal infection that could lead to a number of serious vision
problems, including blindness.
Although the FDA has not yet found a direct link between
the Fusarium fungus in question and this particular product,
26 of the victims had used the ReNu MoistureLoc solution.
This scare comes on the heels of a similar Bausch & Lomb
freeze of product shipment in Hong Kong and Singapore in
February of 2006 caused by reports of eye infections.
Fungal eye infections are serious conditions that can cause
significant damage to victims, often without prior warning.
The Fusarium bacteria in particular can lead to an infection
of the cornea, the delicate tissue covering the pupil. Even
relatively minor eye infections can lead to irritation, distort
vision, and in some tragic cases, cause permanent blindness.
The FDA reported that Bausch & Lomb was not presently
removing any of its existing MoistureLoc product from U.S.
stores, but the agency urged the millions of Americans who
wear soft contact lenses to make sure to remain vigilant
and to keep their hands and lens cases clean.
Rochester, New York-based Bausch & Lomb was founded
in 1853 and has since grown into one of the world’s
largest suppliers of optic supplies. The company earned over
$2.23 billion in revenues last year and before recent problems
had been positioned to take over an even greater share of
the optics market next year. This particular halt was a further
blow to the company, which last month had announced a delay
in issuing its 2005 annual report amid internal accounting
investigations.
Consumers deserve to be informed about any potential risks
of products, and companies who compromise public safety should
be held accountable. If you developed an eye infection due
to ReNu MoistureLoc brand contact lens solution, the experienced
attorneys at Atkins & Markoff would like to talk to you.
Don’t suffer in silence - let our experienced and compassionate
defective drug legal team help you get the answers and the
compensation that you are entitled to.
September 28, 2004
The FDA announced the voluntary recall of the COX-2 inhibitor
rofecoxib, VIOXX, by Merck & Co. Inc. Clinical tests proving
an increased risk of heart attacks and strokes in patients
using Vioxx prompted the recall.
Click here to learn more about Vioxx and Vioxx side effects
OKLAHOMA CITY (Aug. 18) -- State Representative Leonard Sullivan
probably would never have met Lynn Starks if it hadn't been
for a bunk bed.
Read Article
|
